Cargando…
Production of a Soluble Recombinant Antibody Fragment against MMP9 Using Escherichia coli
Matrix metalloproteinase 9 (MMP9) is involved in several aspects of the pathology of cancer, including invasion, metastasis, and angiogenesis. In this study, we expressed a recombinant scFv-type anti-MMP9 antibody in soluble form using Escherichia coli, purified it, and confirmed its antigen-binding...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468072/ https://www.ncbi.nlm.nih.gov/pubmed/34577904 http://dx.doi.org/10.3390/medicina57090981 |
_version_ | 1784573566916755456 |
---|---|
author | Yeom, Chang-Hun Jeong, Hee-Jin |
author_facet | Yeom, Chang-Hun Jeong, Hee-Jin |
author_sort | Yeom, Chang-Hun |
collection | PubMed |
description | Matrix metalloproteinase 9 (MMP9) is involved in several aspects of the pathology of cancer, including invasion, metastasis, and angiogenesis. In this study, we expressed a recombinant scFv-type anti-MMP9 antibody in soluble form using Escherichia coli, purified it, and confirmed its antigen-binding ability. The convenient, rapid, inexpressive system used in this study for producing recombinant antibody fragments needs only five days, and thus can be used for the efficient production of scFv against MMP9, which can be used in a range of applications and industrial fields, including diagnosis and treatment of inflammatory and cancer-related diseases. |
format | Online Article Text |
id | pubmed-8468072 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84680722021-09-27 Production of a Soluble Recombinant Antibody Fragment against MMP9 Using Escherichia coli Yeom, Chang-Hun Jeong, Hee-Jin Medicina (Kaunas) Communication Matrix metalloproteinase 9 (MMP9) is involved in several aspects of the pathology of cancer, including invasion, metastasis, and angiogenesis. In this study, we expressed a recombinant scFv-type anti-MMP9 antibody in soluble form using Escherichia coli, purified it, and confirmed its antigen-binding ability. The convenient, rapid, inexpressive system used in this study for producing recombinant antibody fragments needs only five days, and thus can be used for the efficient production of scFv against MMP9, which can be used in a range of applications and industrial fields, including diagnosis and treatment of inflammatory and cancer-related diseases. MDPI 2021-09-18 /pmc/articles/PMC8468072/ /pubmed/34577904 http://dx.doi.org/10.3390/medicina57090981 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Yeom, Chang-Hun Jeong, Hee-Jin Production of a Soluble Recombinant Antibody Fragment against MMP9 Using Escherichia coli |
title | Production of a Soluble Recombinant Antibody Fragment against MMP9 Using Escherichia coli |
title_full | Production of a Soluble Recombinant Antibody Fragment against MMP9 Using Escherichia coli |
title_fullStr | Production of a Soluble Recombinant Antibody Fragment against MMP9 Using Escherichia coli |
title_full_unstemmed | Production of a Soluble Recombinant Antibody Fragment against MMP9 Using Escherichia coli |
title_short | Production of a Soluble Recombinant Antibody Fragment against MMP9 Using Escherichia coli |
title_sort | production of a soluble recombinant antibody fragment against mmp9 using escherichia coli |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468072/ https://www.ncbi.nlm.nih.gov/pubmed/34577904 http://dx.doi.org/10.3390/medicina57090981 |
work_keys_str_mv | AT yeomchanghun productionofasolublerecombinantantibodyfragmentagainstmmp9usingescherichiacoli AT jeongheejin productionofasolublerecombinantantibodyfragmentagainstmmp9usingescherichiacoli |